Research reveals novel magnesium complexes with unique cyclopentadienyl ligands, indicating modular synthesis potential.
The first Mg I complexes with non‐N ligands have been isolated and were fully characterized. Reaction of [(BDI*)MgNa] 2 ( III ) with MgCp* 2 gave quantitative conversion to (BDI*)MgMgCp* ( 1 ); BDI* = HC[ t BuC = N(DIPeP)] 2 , DIPeP = 2,6‐Et 2 CH‐phenyl) and Cp* = pentamethylcyclopentadienyl. A similar reaction with CaCp* 2 did not give (BDI*)MgCaCp* but led to insertion of the formal Mg° centre in the benzylic C─H bond, an oxidative addition that resulted in a mixed Mg/Ca hydride complex. The Cp* ligand in the unique (BDI*)MgMgCp* complex can be exchanged by addition of LM (M = Li, Na, K) complexes, resulting in formation of (BDI*)MgMgL and insoluble (Cp*M) n . This modular approach worked for Cp*/N(SiMe 3 ) 2 exchange but not for the substitution of Cp* by P(SiMe 3 ) 2 or other PR 2 ligands. Reaction of (BDI*)MgMgCp* with a bulky NaOAr reagent led to quantitative formation of (BDI*)MgMgOAr·THF, a first Mg I complex stabilized with an aryloxide ligand. All products have been fully characterized by X‐ray diffraction and NMR methods. A computational study gives insight in the thermodynamics of formation and electronic structures.
No takes yet. Share an insight, caveat, or question.
Stecher et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: